BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29794740)

  • 1. Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.
    Russano de Paiva Silva G; Tournier E; Sarian LO; Bulai-Livideanu C; Delsol G; Lamant L; Vassallo J; Brousset P; Laurent C
    Medicine (Baltimore); 2018 May; 97(21):e10642. PubMed ID: 29794740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.
    Sotlar K; Cerny-Reiterer S; Petat-Dutter K; Hessel H; Berezowska S; Müllauer L; Valent P; Horny HP
    Mod Pathol; 2011 Apr; 24(4):585-95. PubMed ID: 21186345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms.
    Valent P; Sotlar K; Horny HP
    Leuk Lymphoma; 2011 May; 52(5):740-4. PubMed ID: 21261503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.
    Blatt K; Cerny-Reiterer S; Schwaab J; Sotlar K; Eisenwort G; Stefanzl G; Hoermann G; Mayerhofer M; Schneeweiss M; Knapp S; Rülicke T; Hadzijusufovic E; Bauer K; Smiljkovic D; Willmann M; Reiter A; Horny HP; Valent P
    Blood; 2015 Dec; 126(26):2832-41. PubMed ID: 26486787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastocytosis and related disorders.
    Chiu A; Orazi A
    Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.
    Sotlar K; Horny HP; Simonitsch I; Krokowski M; Aichberger KJ; Mayerhofer M; Printz D; Fritsch G; Valent P
    Am J Surg Pathol; 2004 Oct; 28(10):1319-25. PubMed ID: 15371947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
    Sotlar K; George TI; Kluin P; Reiter A; Schwaab J; Panse J; Brockow K; Hartmann K; Sperr WR; Kristensen T; Nedoszytko B; Carter M; Bonadonna P; Lyons JJ; Kluin-Nelemans HC; Hermine O; Akin C; Broesby-Olsen S; Hoermann G; Triggiani M; Butterfield JH; Jawhar M; Gotlib J; Metcalfe DD; Orfao A; Arock M; Valent P; Horny HP
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1986-1998.e2. PubMed ID: 35724949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mastocytosis, classification, biological diagnosis and therapy].
    Arock M
    Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of extramedullary mastocytosis.
    Doyle LA; Hornick JL
    Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expressions of CD30 and CD123 of Mastocytosis in Taiwan.
    Yang CF; Hsu CY
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):278-283. PubMed ID: 35384878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis: from a Molecular Point of View.
    Komi DEA; Rambasek T; Wöhrl S
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):397-411. PubMed ID: 28725969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.